J. Folkman, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nature Medicine, vol.326, issue.1, pp.27-31, 1995.
DOI : 10.1038/359845a0

A. P. Adamis, L. P. Aiello, D. Amato, and R. A. , Angiogenesis and ophthalmic disease, Angiogenesis, vol.3, issue.1, pp.9-14, 1999.
DOI : 10.1023/A:1009071601454

R. G. Knowles and S. Moncada, Nitric oxide synthases in mammals, Biochemical Journal, vol.298, issue.2, pp.249-258, 1994.
DOI : 10.1042/bj2980249

K. S. Christopherson and D. S. Bredt, Nitric oxide in excitable tissues: physiological roles and disease., Journal of Clinical Investigation, vol.100, issue.10, pp.2424-2429, 1997.
DOI : 10.1172/JCI119783

J. Macmicking, Q. W. Xie, N. , and C. , NITRIC OXIDE AND MACROPHAGE FUNCTION, Annual Review of Immunology, vol.15, issue.1, pp.323-350, 1997.
DOI : 10.1146/annurev.immunol.15.1.323

F. C. Fang, Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity., Journal of Clinical Investigation, vol.99, issue.12, pp.2818-2825, 1997.
DOI : 10.1172/JCI119473

C. Nathan, Inducible nitric oxide synthase: what difference does it make?, Journal of Clinical Investigation, vol.100, issue.10, pp.2417-2423, 1997.
DOI : 10.1172/JCI119782

A. Parenti, Nitric Oxide Is an Upstream Signal of Vascular Endothelial Growth Factor-induced Extracellular Signal-regulated Kinase1/2 Activation in Postcapillary Endothelium, Journal of Biological Chemistry, vol.273, issue.7, pp.4220-4226, 1998.
DOI : 10.1074/jbc.273.7.4220

M. Ziche, Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis., Journal of Clinical Investigation, vol.99, issue.11, pp.2625-2634, 1997.
DOI : 10.1172/JCI119451

A. Papapetropoulos, G. Garcia-cardena, J. A. Madri, and W. C. Sessa, Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells., Journal of Clinical Investigation, vol.100, issue.12, pp.3131-3139, 1997.
DOI : 10.1172/JCI119868

Y. Tsurumi, Reciprocal relation between VEGF and NO in the regulation of endothelial integrity, Nature Medicine, vol.92, issue.8, pp.879-886, 1997.
DOI : 10.1126/SCIENCE.275.5302.964

Y. Liu, Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5' Enhancer, Journal of Biological Chemistry, vol.273, issue.24, pp.15257-15262, 1998.
DOI : 10.1074/jbc.273.24.15257

R. M. Tuder, B. E. Flook, and N. F. Voelkel, Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide., Journal of Clinical Investigation, vol.95, issue.4, pp.1798-1807, 1995.
DOI : 10.1172/JCI117858

D. Fulton, Regulation of endothelium-derived nitric oxide production by the protein kinase Akt, Nature, vol.400, issue.399, pp.792597-601, 1999.

T. Murohara, Nitric oxide synthase modulates angiogenesis in response to tissue ischemia., Journal of Clinical Investigation, vol.101, issue.11, pp.2567-2578, 1998.
DOI : 10.1172/JCI1560

F. Sennlaub, Y. Courtois, and O. Goureau, Nitric oxide synthase- II is expressed in severe corneal alkali burns and inhibits neovascularization, Invest. Ophthalmol. Vis. Sci, vol.40, pp.2773-2779, 1999.

E. Pipili-synetos, Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chick chorioallantoic membrane, British Journal of Pharmacology, vol.192, issue.1, pp.207-213, 2000.
DOI : 10.1038/sj.bjp.0702986

J. D. Macmicking, Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase, Cell, vol.81, issue.4, pp.1170641-650, 1995.
DOI : 10.1016/0092-8674(95)90085-3

L. E. Smith, Oxygen-induced retinopathy in the mouse, Invest. Ophthalmol. Vis. Sci, vol.35, pp.101-111, 1994.

E. P. Garvey, 1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo, Journal of Biological Chemistry, vol.272, issue.8, pp.4959-4963, 1997.
DOI : 10.1074/jbc.272.8.4959

O. Goureau, J. Bellot, B. Thillaye, Y. Courtois, and Y. De-kozak, Increased nitric oxide production in endotoxin-induced uveitis. Reduction of uveitis by an inhibitor of nitric oxide synthase, J. Immunol, vol.154, pp.6518-6523, 1995.

V. Thaker, In Situ RT-PCR and Hybridization Techniques, Methods Mol. Biol, vol.115, pp.379-402, 1999.
DOI : 10.1385/1-59259-213-9:379

B. T. Hope, G. J. Michael, K. M. Knigge, and S. R. Vincent, Neuronal NADPH diaphorase is a nitric oxide synthase., Proc. Natl. Acad. Sci. USA, pp.2811-2814, 1991.
DOI : 10.1073/pnas.88.7.2811
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC51329

T. Matsumoto, M. Nakane, J. S. Pollock, J. E. Kuk, and U. Forstermann, A correlation between soluble brain nitric oxide synthase and NADPH-diaphorase activity is only seen after exposure of the tissue to fixative, Neuroscience Letters, vol.155, issue.1, pp.61-64, 1993.
DOI : 10.1016/0304-3940(93)90673-9

L. P. Aiello, Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins., Proc. Natl. Acad. Sci. USA, pp.10457-10461, 1995.
DOI : 10.1073/pnas.92.23.10457

P. N. Bernatchez, S. Soker, and M. G. Sirois, Vascular Endothelial Growth Factor Effect on Endothelial Cell Proliferation, Migration, and Platelet-activating Factor Synthesis Is Flk-1-dependent, Journal of Biological Chemistry, vol.274, issue.43, pp.31047-31054, 1999.
DOI : 10.1074/jbc.274.43.31047

G. Melillo, A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter, Journal of Experimental Medicine, vol.182, issue.6, pp.1683-1693, 1995.
DOI : 10.1084/jem.182.6.1683

L. A. Palmer, G. L. Semenza, M. H. Stoler, and R. A. Johns, Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1, Am. J. Physiol, vol.274, pp.212-219, 1998.

H. Ozaki, Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression, Invest. Ophthalmol. Vis. Sci, vol.40, pp.182-189, 1999.

A. Yoshida, S. Yoshida, T. Ishibashi, M. Kuwano, and H. Inomata, Suppression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbamate in mice, Invest. Ophthalmol. Vis. Sci, vol.40, pp.1624-1629, 1999.

O. Goureau, D. Hicks, Y. Courtois, D. Kozak, and Y. , Induction and Regulation of Nitric Oxide Synthase in Retinal M??ller Glial Cells, Journal of Neurochemistry, vol.63, issue.1, pp.310-317, 1994.
DOI : 10.1046/j.1471-4159.1994.63010310.x

D. 'amore and P. A. , Mechanisms of retinal and choroidal neovascularization, Invest. Ophthalmol. Vis. Sci, vol.35, pp.3974-3979, 1994.

C. Favard, N. Ortega, F. Bayard, and J. Plouet, Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy, Diabetes Metab, vol.22, pp.268-273, 1996.

N. Ghiso, R. M. Rohan, S. Amano, R. Garland, and A. P. Adamis, Suppression of hypoxia-associated vascular endothelial growth factor gene expression by nitric oxide via cGMP, Invest. Ophthalmol. Vis. Sci, vol.40, pp.1033-1039, 1999.

B. Q. Shen, Homologous Up-regulation of KDR/Flk-1 Receptor Expression by Vascular Endothelial Growth Factor in Vitro, Journal of Biological Chemistry, vol.273, issue.45, pp.29979-29985, 1998.
DOI : 10.1074/jbc.273.45.29979

K. Suzuma, H. Takagi, A. Otani, I. Suzuma, and Y. Honda, Increased Expression of KDR/Flk-1 (VEGFR-2) in Murine Model of Ischemia-Induced Retinal Neovascularization, Microvascular Research, vol.56, issue.3, pp.183-191, 1998.
DOI : 10.1006/mvre.1998.2111

J. Stone, Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity, Invest. Ophthalmol. Vis. Sci, vol.37, pp.290-299, 1996.